California State Teachers Retirement System (CalSTRS)
CASC

California State Teachers Retirement System (CalSTRS)’s Cascadian Therapeutics, Inc. CASC Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-55,489
Closed -$205K – 2982
2017
Q4 		$205K Sell
55,489
-811
-1% -$3.32K ﹤0.01% 2818
2017
Q3 		$230K Sell
56,300
-4,400
-7% -$16.8K ﹤0.01% 2840
2017
Q2 		$226K Buy
+60,700
New +$241K ﹤0.01% 2895
2016
Q2 		– Sell
-33,961
Closed -$259K – 3086
2016
Q1 		$259K Buy
33,961
+4,654
+16% +$35.8K ﹤0.01% 2729
2015
Q4 		$390K Buy
29,307
+517
+2% +$8.9K ﹤0.01% 2583
2015
Q3 		$473K Sell
28,790
-2,350
-8% -$48.2K ﹤0.01% 2456
2015
Q2 		$699K Buy
31,140
+2,510
+9% +$39.7K ﹤0.01% 2337
2015
Q1 		$280K Buy
28,630
+3,684
+15% +$36.1K ﹤0.01% 2772
2014
Q4 		$284K Buy
24,946
+106
+0.4% +$1.15K ﹤0.01% 2814
2014
Q3 		$286K Buy
24,840
+3,307
+15% +$50.5K ﹤0.01% 2755
2014
Q2 		$419K Buy
+21,533
New +$380K ﹤0.01% 2609

California State Teachers Retirement System (CalSTRS)'s CASC Position: Q1 2018 in Review

California State Teachers Retirement System (CalSTRS) sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 55,489 shares — an estimated $205K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CASC in Q2 2014 and held it in 11 quarters. The position peaked at $699K in Q2 2015. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 55,489 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $205K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Cascadian Therapeutics, Inc. in Q2 2014 and held it in 11 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Cascadian Therapeutics, Inc. position peaked at $699K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2018, filed 15 May 2018.